论文部分内容阅读
市场前景黯淡,IPO退出不畅,急于退出的LP纷纷到二级市场寻找出路。2012年3月2日,鼎晖投资、中信产业投资基金及新天域资本,从安博凯(MBK Partners)手中收购了绿叶制药集团有限公司55%的股权。这笔看似不起眼的份额转让,在业内人士看来,却有着非凡的意义。“这是PE购买PE所持有投资组合公司权益的交易,交易双方均为财务投资者。对于卖方而言,是获利退出;对于买方而言,是投资操作的开始。”上海基母股权投资基金管理有限公司创始
Dimming market prospects, IPO exit poor, anxious to exit the LP have to find a way out of the secondary market. On March 2, 2012, CDH Investments, CITIC Industrial Investment Fund and Xin Tian Tian Capital acquired a 55% stake in Luye Pharmaceutical Group Co., Ltd. from MBK Partners. This seemingly humble share of the transfer, it seems in the industry, but it has an extraordinary significance. “This is a PE transaction where PE buys a portfolio company’s equity held by PE, both parties being financial investors. It is a profit-taking exit for the seller, and the buyer is the beginning of an investment operation.” " Capital Equity Fund Management Co., Ltd. founding